­
­
­
­

Inventi Impact: Gastroenterology

Articles

  • Inventi:hgst/28038/19
    Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic\nHepatitis C Virus Infection
    Research 2019 : April - June
    Yi-Ling Ko, Daisuke Morihara, Kumiko Shibata, Ryo Yamauchi, Hiromi Fukuda, Hideo Kunimoto, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Keiji Yokoyama, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka

    Zinc deficiency is frequently observed in chronic liver diseases. However, no studies\nhave focused on the zinc status in chronic hepatitis C (HCV)-infected patients receiving direct-acting\nantiviral agents (DAAs). In this retrospective study, we assessed the serum zinc status in DAA-treated\nHCV patients with sustained virologic response for over two years (Zn-2y). Ninety-five patients\nwere enrolled, whose baseline characteristics and blood parameters at DAA therapy initiation\nwere collected.

    How to Cite this Article
    CC Compliant Citation: Ko, Yi-Ling, et al. \"Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral\nAgent-Treated Chronic Hepatitis C Virus Infection.\" Nutrients 10.11 (2018): 1620, doi:10.3390/nu10111620, http://\ncreativecommons.org/licenses/by/4.0/.
    Download Full Text